Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Trial Profile

Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Efinaconazole (Primary)
  • Indications Onychomycosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Dow Pharmaceutical Sciences
  • Most Recent Events

    • 01 Apr 2017 Results of post-hoc pooled analysis comparing data for Latino (n=270) versus non-Latino populations (n=1380) of the two pivotal studies (NCT01007708 and NCT01008033), published in the Cutis Journal.
    • 05 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top